{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:26:26Z","timestamp":1790126786081,"version":"4.0.1"},"reference-count":91,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.idc.2022.02.009","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T18:41:07Z","timestamp":1663267267000},"page":"655-670","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Human Babesiosis"],"prefix":"10.1016","volume":"36","author":[{"given":"Rami","family":"Waked","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.idc.2022.02.009_bib1","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.ss6806a1","article-title":"Babesiosis surveillance \u2014 United States, 2011\u20132015","volume":"68","author":"Gray","year":"2019","journal-title":"MMWR Surveill Summ"},{"issue":"2","key":"10.1016\/j.idc.2022.02.009_bib2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.idc.2015.02.008","article-title":"Babesiosis","volume":"29","author":"Vannier","year":"2015","journal-title":"Infect Dis Clin North Am"},{"issue":"2","key":"10.1016\/j.idc.2022.02.009_bib3","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/jcm.35.2.450-454.1997","article-title":"Human babesiosis in Taiwan: asymptomatic infection with a Babesia microti-like organism in a Taiwanese woman","volume":"35","author":"Shih","year":"1997","journal-title":"J\u00a0Clin Microbiol"},{"issue":"1","key":"10.1016\/j.idc.2022.02.009_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ttbdis.2009.11.003","article-title":"Zoonotic babesiosis: overview of the disease and novel aspects of pathogen identity","volume":"1","author":"Gray","year":"2010","journal-title":"Ticks Tick Borne Dis"},{"issue":"7","key":"10.1016\/j.idc.2022.02.009_bib5","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/14787210.2020.1752193","article-title":"Management strategies for human babesiosis","volume":"18","author":"Smith","year":"2020","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"7","key":"10.1016\/j.idc.2022.02.009_bib7","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.ijpara.2006.03.008","article-title":"Description of Babesia duncani n.sp. (Apicomplexa: Babesiidae) from humans and its differentiation from other piroplasms","volume":"36","author":"Conrad","year":"2006","journal-title":"Int J Parasitol"},{"issue":"4","key":"10.1016\/j.idc.2022.02.009_bib8","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3201\/eid1004.030377","article-title":"Babesia divergens-like infection, Washington State","volume":"10","author":"Herwaldt","year":"2004","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2022.02.009_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1550-7408.1980.tb04228.x","article-title":"A\u00a0newly revised classification of the protozoa","volume":"27","author":"Levine","year":"1980","journal-title":"J\u00a0Protozool"},{"issue":"7","key":"10.1016\/j.idc.2022.02.009_bib10","doi-asserted-by":"crossref","first-page":"16079","DOI":"10.1038\/nmicrobiol.2016.79","article-title":"A\u00a0global map of genetic diversity in Babesia microti reveals strong population structure and identifies variants associated with clinical relapse","volume":"1","author":"Lemieux","year":"2016","journal-title":"Nat Microbiol"},{"issue":"3","key":"10.1016\/j.idc.2022.02.009_bib11","doi-asserted-by":"crossref","first-page":"e0193837","DOI":"10.1371\/journal.pone.0193837","article-title":"Zoonotic Babesia microti in the northeastern U.S.: evidence for the expansion of a specific parasite lineage","volume":"13","author":"Goethert","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.idc.2022.02.009_bib12","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev.en.30.010185.002255","article-title":"Ecology of Ixodes dammini-borne human babesiosis and Lyme disease","volume":"30","author":"Spielman","year":"1985","journal-title":"Annu Rev Entomol"},{"key":"10.1016\/j.idc.2022.02.009_bib13","series-title":"Parasitic Protozoa","first-page":"1","article-title":"CHAPTER 1 - Babesial infections in humans and wildlife","author":"Telford","year":"1993"},{"issue":"10","key":"10.1016\/j.idc.2022.02.009_bib14","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/infdis\/jiaa595","article-title":"Vertical transmission: a vector-independent transmission pathway of Babesia microti in the natural reservoir host Peromyscus leucopus","volume":"223","author":"Tufts","year":"2021","journal-title":"J\u00a0Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2022.02.009_bib15","doi-asserted-by":"crossref","first-page":"739","DOI":"10.4269\/ajtmh.1998.58.739","article-title":"Diversity of Babesia infecting deer ticks (Ixodes dammini)","volume":"58","author":"Armstrong","year":"1998","journal-title":"Am J Trop Med Hyg"},{"issue":"25","key":"10.1016\/j.idc.2022.02.009_bib16","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1056\/NEJMra1202018","article-title":"Human babesiosis","volume":"366","author":"Vannier","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.idc.2022.02.009_bib17","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1056\/NEJMoa1600897","article-title":"Screening for Babesia microti in the U.S. blood supply","volume":"375","author":"Moritz","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.idc.2022.02.009_bib18","doi-asserted-by":"crossref","first-page":"509","DOI":"10.7326\/0003-4819-155-8-201110180-00362","article-title":"Transfusion-associated babesiosis in the United States: a description of cases","volume":"155","author":"Herwaldt","year":"2011","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.idc.2022.02.009_bib19","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3201\/eid1505.081562","article-title":"Babesiosis acquired through blood transfusion, California, USA","volume":"15","author":"Ngo","year":"2009","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2022.02.009_bib20","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1111\/j.1537-2995.2009.02494.x","article-title":"The problem of transfusion-transmitted babesiosis","volume":"49","author":"Young","year":"2009","journal-title":"Transfusion"},{"issue":"11","key":"10.1016\/j.idc.2022.02.009_bib21","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.3201\/eid2211.151028","article-title":"Transmission of babesia microti parasites by solid organ transplantation","volume":"22","author":"Brennan","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2022.02.009_bib22","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/IPC.0b013e3182769089","article-title":"Transplacental transmission of human babesiosis","volume":"20","author":"Krause","year":"2012","journal-title":"Infect Dis Clin Pract"},{"issue":"11","key":"10.1016\/j.idc.2022.02.009_bib23","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.3201\/eid2411.170512","article-title":"Human babesiosis, Yucat\u00e1n State, Mexico, 2015","volume":"24","author":"Peniche-Lara","year":"2018","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2022.02.009_bib24","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.medmal.2019.08.007","article-title":"Human babesiosis in Alsace","volume":"50","author":"Paleau","year":"2020","journal-title":"Med Mal Infect"},{"issue":"1","key":"10.1016\/j.idc.2022.02.009_bib25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4269\/ajtmh.18-0012","article-title":"Babesia microti and malaria infection in Africa: a pilot serosurvey in Kilosa District, Tanzania","volume":"99","author":"Bloch","year":"2018","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.idc.2022.02.009_bib26","first-page":"509","article-title":"Human babesiosis, an emerging tick-borne disease in the People\u2019s Republic of China","volume":"7","author":"Zhou","year":"2014","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.idc.2022.02.009_bib27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.exppara.2014.03.004","article-title":"Molecular confirmation of the first autochthonous case of human babesiosis in Australia using a novel primer set for the beta-tubulin gene","volume":"141","author":"Paparini","year":"2014","journal-title":"Exp Parasitol"},{"issue":"6","key":"10.1016\/j.idc.2022.02.009_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6806a1","article-title":"Babesiosis surveillance - United States, 2011-2015","volume":"68","author":"Gray","year":"2019","journal-title":"MMWR Surveill Summ"},{"issue":"4","key":"10.1016\/j.idc.2022.02.009_bib29","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4269\/ajtmh.2003.68.431","article-title":"Increasing health burden of human babesiosis in endemic sites","volume":"68","author":"Krause","year":"2003","journal-title":"Am J Trop Med Hyg"},{"issue":"12","key":"10.1016\/j.idc.2022.02.009_bib30","doi-asserted-by":"crossref","first-page":"e115494","DOI":"10.1371\/journal.pone.0115494","article-title":"Borrelia burgdorferi promotes the establishment of Babesia microti in the northeastern United States","volume":"9","author":"Dunn","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.idc.2022.02.009_bib31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.pt.2015.09.008","article-title":"Coinfection by the tick-borne pathogens Babesia microti and Borrelia burgdorferi: ecological, epidemiological and clinical consequences","volume":"32","author":"Diuk-Wasser","year":"2016","journal-title":"Trends Parasitol"},{"issue":"11","key":"10.1016\/j.idc.2022.02.009_bib32","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1111\/j.1537-2995.2005.00609.x","article-title":"Demonstrable parasitemia among Connecticut blood donors with antibodies to Babesia microti","volume":"45","author":"Leiby","year":"2005","journal-title":"Transfusion"},{"issue":"8","key":"10.1016\/j.idc.2022.02.009_bib33","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1111\/j.1537-2995.2012.03948.x","article-title":"Babesia microti seroprevalence in Minnesota blood donors","volume":"53","author":"Tonnetti","year":"2013","journal-title":"Transfusion"},{"issue":"9","key":"10.1016\/j.idc.2022.02.009_bib34","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1111\/trf.12693","article-title":"Investigational screening for Babesia microti in a large repository of blood donor samples from nonendemic and endemic areas of the United States","volume":"54","author":"Moritz","year":"2014","journal-title":"Transfusion"},{"issue":"12","key":"10.1016\/j.idc.2022.02.009_bib35","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.pt.2007.09.005","article-title":"Shared features in the pathobiology of babesiosis and malaria","volume":"23","author":"Krause","year":"2007","journal-title":"Trends Parasitol"},{"issue":"5","key":"10.1016\/j.idc.2022.02.009_bib36","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jvir.2011.01.439","article-title":"Spontaneous splenic rupture secondary to Babesia microti infection: treatment with splenic artery embolization","volume":"22","author":"Reis","year":"2011","journal-title":"J\u00a0Vasc Interv Radiol"},{"issue":"3","key":"10.1016\/j.idc.2022.02.009_bib37","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1056\/NEJM199807163390304","article-title":"Persistent parasitemia after acute babesiosis","volume":"339","author":"Krause","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.idc.2022.02.009_bib38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1471-4922(02)00065-X","article-title":"Babesiosis: persistence in the face of adversity","volume":"19","author":"Allred","year":"2003","journal-title":"Trends Parasitol"},{"issue":"3","key":"10.1016\/j.idc.2022.02.009_bib39","doi-asserted-by":"crossref","first-page":"E95","DOI":"10.3390\/pathogens8030095","article-title":"Babesia divergens: a drive to survive","volume":"8","author":"Lobo","year":"2019","journal-title":"Pathogens"},{"issue":"3","key":"10.1016\/j.idc.2022.02.009_bib40","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/MOH.0b013e328352245a","article-title":"Babesia and red cell invasion","volume":"19","author":"Lobo","year":"2012","journal-title":"Curr Opin Hematol"},{"issue":"10","key":"10.1016\/j.idc.2022.02.009_bib41","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1056\/NEJMoa1612165","article-title":"Post-babesiosis warm autoimmune hemolytic anemia","volume":"376","author":"Woolley","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1016\/j.idc.2022.02.009_bib42","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/jama.1996.03530450047031","article-title":"Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness","volume":"275","author":"Krause","year":"1996","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.idc.2022.02.009_bib43","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1086\/339813","article-title":"Disease-specific diagnosis of coinfecting tickborne zoonoses: babesiosis, human granulocytic ehrlichiosis, and Lyme disease","volume":"34","author":"Krause","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"19","key":"10.1016\/j.idc.2022.02.009_bib44","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1001\/archinte.158.19.2149","article-title":"Human babesiosis in New York State: review of 139 hospitalized cases and analysis of prognostic factors","volume":"158","author":"White","year":"1998","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.idc.2022.02.009_bib45","doi-asserted-by":"crossref","first-page":"6","DOI":"10.7326\/0003-4819-86-1-6","article-title":"Human babesiosis on Nantucket Island. Clinical features","volume":"86","author":"Reubush","year":"1977","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.idc.2022.02.009_bib46","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/319742","article-title":"Severe babesiosis in Long Island: review of 34 cases and their complications","volume":"32","author":"Hatcher","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2022.02.009_bib47","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/cid\/ciy1060","article-title":"Babesiosis-associated splenic rupture: case series from a hyperendemic region","volume":"69","author":"Patel","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2022.02.009_bib48","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1309\/AJCP2PHH4HBVHZFS","article-title":"Neutropenia in congenital and adult babesiosis","volume":"144","author":"Wormser","year":"2015","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.idc.2022.02.009_bib49","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1086\/520302","article-title":"Relative bradycardia and lymphopenia in patients with babesiosis","volume":"26","author":"Kim","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2022.02.009_bib50","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/ibd.21158","article-title":"Babesiosis in a patient on infliximab for Crohn\u2019s disease","volume":"16","author":"Cullen","year":"2010","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"10.1016\/j.idc.2022.02.009_bib51","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/cid\/cis046","article-title":"Severe babesiosis in a patient treated with a tumor necrosis factor \u03b1 antagonist","volume":"54","author":"Bogoch","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2022.02.009_bib52","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.4269\/ajtmh.17-0146","article-title":"Risk factors for severe infection, hospitalization, and prolonged antimicrobial therapy in patients with babesiosis","volume":"97","author":"Mareedu","year":"2017","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.idc.2022.02.009_bib53","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/00325481.2019.1558910","article-title":"Babesiosis as a cause of acute respiratory distress syndrome: a series of eight cases","volume":"131","author":"Alvarez De Leon","year":"2019","journal-title":"Postgrad Med"},{"key":"10.1016\/j.idc.2022.02.009_bib54","doi-asserted-by":"crossref","first-page":"335","DOI":"10.12659\/AJCR.908453","article-title":"Splenic rupture as the first manifestation of babesia microti infection: report of a case and review of literature","volume":"19","author":"Dumic","year":"2018","journal-title":"Am J Case Rep"},{"issue":"6","key":"10.1016\/j.idc.2022.02.009_bib55","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.ttbdis.2018.06.004","article-title":"Splenic rupture from babesiosis, an emerging concern? A systematic review of current literature","volume":"9","author":"Li","year":"2018","journal-title":"Ticks Tick Borne Dis"},{"issue":"3","key":"10.1016\/j.idc.2022.02.009_bib56","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/525852","article-title":"Persistent and relapsing babesiosis in immunocompromised patients","volume":"46","author":"Krause","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2022.02.009_bib57","doi-asserted-by":"crossref","first-page":"ofz311","DOI":"10.1093\/ofid\/ofz311","article-title":"Babesiosis: a retrospective review of 38 cases in the upper midwest","volume":"6","author":"Fida","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2022.02.009_bib58","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3201\/eid1705.101334","article-title":"Babesiosis in Lower Hudson Valley, New York, USA","volume":"17","author":"Joseph","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2022.02.009_bib59","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1086\/649859","article-title":"Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection","volume":"50","author":"Wormser","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2022.02.009_bib60","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/clinids\/22.5.809","article-title":"Babesiosis in patients with AIDS: a chronic infection presenting as fever of unknown origin","volume":"22","author":"Falagas","year":"1996","journal-title":"Clin Infect Dis"},{"issue":"22","key":"10.1016\/j.idc.2022.02.009_bib61","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMcpc079011","article-title":"Case records of the Massachusetts General Hospital. Case 17-2007. A 25-year-old woman with relapsing fevers and recent onset of dyspnea","volume":"356","author":"Stowell","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.idc.2022.02.009_bib62","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.3201\/eid2710.211240","article-title":"Recurrence of human babesiosis caused by reinfection","volume":"27","author":"Ho","year":"2021","journal-title":"Emerg Infect Dis"},{"issue":"16","key":"10.1016\/j.idc.2022.02.009_bib63","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1001\/jama.2016.2884","article-title":"Diagnosis, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: a review","volume":"315","author":"Sanchez","year":"2016","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.idc.2022.02.009_bib64","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.diagmicrobio.2015.03.010","article-title":"Comparison of a quantitative PCR assay with peripheral blood smear examination for detection and quantitation of Babesia microti infection in humans","volume":"82","author":"Wang","year":"2015","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2022.02.009_bib65","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1128\/JCM.05848-11","article-title":"A\u00a0new real-time PCR assay for improved detection of the parasite Babesia microti","volume":"50","author":"Teal","year":"2012","journal-title":"J\u00a0Clin Microbiol"},{"issue":"11","key":"10.1016\/j.idc.2022.02.009_bib66","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1089\/vbz.2011.0935","article-title":"Quantitative PCR for detection of Babesia microti in Ixodes scapularis ticks and in human blood","volume":"13","author":"Rollend","year":"2013","journal-title":"Vector Borne Zoonotic Dis"},{"key":"10.1016\/j.idc.2022.02.009_bib67","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.exppara.2014.12.003","article-title":"Development of droplet digital PCR for the detection of Babesia microti and Babesia duncani","volume":"149","author":"Wilson","year":"2015","journal-title":"Exp Parasitol"},{"issue":"2","key":"10.1016\/j.idc.2022.02.009_bib69","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/cid\/ciab050","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America (IDSA): 2020 guideline on diagnosis and management of babesiosis","volume":"72","author":"Krause","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2022.02.009_bib70","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/infdis\/169.4.923","article-title":"Diagnosis of babesiosis: evaluation of a serologic test for the detection of Babesia microti antibody","volume":"169","author":"Krause","year":"1994","journal-title":"J\u00a0Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2022.02.009_bib71","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1111\/trf.12763","article-title":"Determination of Babesia microti seroprevalence in blood donor populations using an investigational enzyme immunoassay","volume":"54","author":"Levin","year":"2014","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.idc.2022.02.009_bib72","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4269\/ajtmh.1981.30.291","article-title":"Development and persistence of antibody in persons infected with Babesia microti","volume":"30","author":"Ruebush","year":"1981","journal-title":"Am J Trop Med Hyg"},{"issue":"8","key":"10.1016\/j.idc.2022.02.009_bib73","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1128\/jcm.34.8.2014-2016.1996","article-title":"Efficacy of immunoglobulin M serodiagnostic test for rapid diagnosis of acute babesiosis","volume":"34","author":"Krause","year":"1996","journal-title":"J\u00a0Clin Microbiol"},{"issue":"7","key":"10.1016\/j.idc.2022.02.009_bib74","doi-asserted-by":"crossref","first-page":"643","DOI":"10.7326\/0003-4819-124-7-199604010-00004","article-title":"A\u00a0fatal case of babesiosis in Missouri: identification of another piroplasm that infects humans","volume":"124","author":"Herwaldt","year":"1996","journal-title":"Ann Intern Med"},{"issue":"Pt 2","key":"10.1016\/j.idc.2022.02.009_bib75","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1017\/S0031182006001387","article-title":"Evaluation of an indirect fluorescence immunoassay for the detection of serum antibodies against Babesia divergens in humans","volume":"134","author":"Duh","year":"2007","journal-title":"Parasitology"},{"issue":"5","key":"10.1016\/j.idc.2022.02.009_bib76","doi-asserted-by":"crossref","first-page":"601","DOI":"10.7326\/0003-4819-96-5-601","article-title":"Successful chemotherapy of transfusion babesiosis","volume":"96","author":"Wittner","year":"1982","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.idc.2022.02.009_bib77","doi-asserted-by":"crossref","first-page":"556","DOI":"10.7326\/0003-4819-97-4-556","article-title":"Therapy of experimental babesiosis","volume":"97","author":"Rowin","year":"1982","journal-title":"Ann Intern Med"},{"issue":"19","key":"10.1016\/j.idc.2022.02.009_bib78","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1001\/jama.1981.03310440038022","article-title":"Treatment of babesiosis in asplenic patients","volume":"245","author":"Bredt","year":"1981","journal-title":"JAMA"},{"issue":"20","key":"10.1016\/j.idc.2022.02.009_bib79","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1056\/NEJM200011163432004","article-title":"Atovaquone and azithromycin for the treatment of babesiosis","volume":"343","author":"Krause","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.idc.2022.02.009_bib80","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/cid\/ciab275","article-title":"Corrigendum to: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA): 2020 guideline on diagnosis and management of babesiosis","volume":"73","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2022.02.009_bib82","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12941-017-0198-9","article-title":"Babesiosis in Long Island: review of 62 cases focusing on treatment with azithromycin and atovaquone","volume":"16","author":"Kletsova","year":"2017","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"7","key":"10.1016\/j.idc.2022.02.009_bib83","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1093\/cid\/cix477","article-title":"Clinical and molecular evidence of atovaquone and azithromycin resistance in relapsed Babesia microti infection associated with rituximab and chronic lymphocytic leukemia","volume":"65","author":"Simon","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2022.02.009_bib84","doi-asserted-by":"crossref","first-page":"ofaa448","DOI":"10.1093\/ofid\/ofaa448","article-title":"Case report: overwhelming babesia parasitemia successfully treated promptly with RBC apheresis and triple therapy with clindamycin, azithromycin, and atovaquone","volume":"7","author":"Li","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2022.02.009_bib85","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.idc.2008.03.010","article-title":"Human babesiosis","volume":"22","author":"Vannier","year":"2008","journal-title":"Infect Dis Clin North Am"},{"issue":"7","key":"10.1016\/j.idc.2022.02.009_bib86","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.20151519","article-title":"Radical cure of experimental babesiosis in immunodeficient mice using a combination of an endochin-like quinolone and atovaquone","volume":"213","author":"Lawres","year":"2016","journal-title":"J\u00a0Exp Med"},{"issue":"3","key":"10.1016\/j.idc.2022.02.009_bib87","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/infdis\/jiz119","article-title":"Could the drug tafenoquine revolutionize treatment of Babesia microti infection?","volume":"220","author":"Mordue","year":"2019","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.idc.2022.02.009_bib88","first-page":"jiab537","article-title":"A\u00a0combination of clofazimine\u2012atovaquone as a potent therapeutic regimen for the radical cure of Babesia microti infection in immunocompromised hosts","volume":"19","author":"Tuvshintulga","year":"2021","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.idc.2022.02.009_bib89","first-page":"jiab538","article-title":"Clofazimine for babesiosis: preclinical data support a clinical trial","volume":"19","author":"Vannier","year":"2021","journal-title":"J\u00a0Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2022.02.009_bib90","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the writing committee of the American Society for Apheresis: the eighth special issue","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"J\u00a0Clin Apher"},{"issue":"3","key":"10.1016\/j.idc.2022.02.009_bib91","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jca.20197","article-title":"Red cell exchange transfusion for babesiosis in Rhode Island","volume":"24","author":"Spaete","year":"2009","journal-title":"J\u00a0Clin Apher"},{"issue":"5","key":"10.1016\/j.idc.2022.02.009_bib92","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/jca.21429","article-title":"Apheresis for babesiosis: therapeutic parasite reduction or removal of harmful toxins or both?","volume":"31","author":"Saifee","year":"2016","journal-title":"J\u00a0Clin Apher"},{"issue":"5","key":"10.1016\/j.idc.2022.02.009_bib93","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.transci.2019.07.010","article-title":"Repeat exchange transfusion for treatment of severe babesiosis","volume":"58","author":"Radcliffe","year":"2019","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.idc.2022.02.009_bib94","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.3389\/fimmu.2020.01437","article-title":"Babesia microti protein BmSP44 is a novel protective antigen in a mouse model of babesiosis","volume":"11","author":"Wang","year":"2020","journal-title":"Front Immunol"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552022000307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552022000307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:30:12Z","timestamp":1760196612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552022000307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":91,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0891552022000307"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2022.02.009","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human Babesiosis","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2022.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}